784 filings
Page 15 of 40
424B5
CRVO
CervoMed Inc
19 May 20
Prospectus supplement for primary offering
5:29pm
D
CRVO
CervoMed Inc
15 May 20
$625K in options / securities to be acquired, sold $625K, 1 investor
4:29pm
S-8
CRVO
CervoMed Inc
13 May 20
Registration of securities for employees
4:52pm
8-K
CRVO
CervoMed Inc
11 May 20
Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
4:58pm
10-Q
2020 Q1
CRVO
CervoMed Inc
Quarterly report
11 May 20
4:02pm
8-K
CRVO
CervoMed Inc
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
CRVO
CervoMed Inc
6 May 20
Entry into a Material Definitive Agreement
9:05am
DEFA14A
CRVO
CervoMed Inc
29 Apr 20
Additional proxy soliciting materials
4:28pm
DEF 14A
CRVO
CervoMed Inc
Definitive proxy
29 Apr 20
4:27pm
8-K
CRVO
CervoMed Inc
29 Apr 20
Diffusion Pharmaceuticals Announces Pre-IND Submission to the FDA of Design for TSC Trials to Treat Acute Respiratory Distress Syndrome in COVID-19
8:44am
PRE 14A
CRVO
CervoMed Inc
Preliminary proxy
17 Apr 20
5:26pm
8-K
CRVO
CervoMed Inc
1 Apr 20
Partnering with University of Virginia Health and iTHRIV
4:41pm
8-K
CRVO
CervoMed Inc
24 Mar 20
Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the Coronavirus
4:41pm
8-K
CRVO
CervoMed Inc
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm
10-K
2019 FY
CRVO
CervoMed Inc
Annual report
17 Mar 20
4:06pm
SC 13G/A
Anson Funds Management LP
14 Feb 20
Beneficial ownership report (amended)
3:52pm
SC 13G/A
Armistice Capital, LLC
14 Feb 20
Diffusion Pharmaceuticals Inc.
11:22am
8-K
CRVO
CervoMed Inc
6 Feb 20
Departure of Directors or Certain Officers
4:39pm
4
CRVO
CervoMed Inc
30 Jan 20
Diffusion Pharmaceuticals / John Gainer ownership change
4:55pm
4
CRVO
CervoMed Inc
30 Jan 20
Diffusion Pharmaceuticals / David G Kalergis ownership change
4:54pm